Single-blinded Randomized Controlled Trial conducted amongst a sample of healthy subjects divided into two different groups: the experimental treatment will consist in bilateral T12-L1 vertebral manipulation, whereas the control group will receive a sham intervention consisting solely in applying tension without properly manipulating. Body temperature, arterial tension and cardiac frequency will be measured before and after the intervention. Changes in the aforementioned variables will be measured.
The current study will correspond to a single-blinded Randomized Controlled Trial with two arms, conducted amongst a sample of healthy subjects, who will be divided into two different groups: the experimental treatment will consist in bilateral T12-L1 vertebral manipulation, whereas the control group will receive a sham intervention consisting solely in applying tension without properly manipulating. Three different variables will be measured prior to and after the intervention: body temperature, arterial tension and cardiac frequency, to subsequently calculate possible changes in the variables, with the aim of establishing the effect of the manipulation and/or sham treatment.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Enrollment
73
Bilateral vertebral manipulation of the T12-L1 vertebra through manual therapy
Manual tension without reaching the manipulation "thrust"
UCAM
Murcia, Spain
Body temperature
Body temperature: Celsius degree will be measured by means of a digital thermometer
Time frame: Change from baseline Body Temperature to ten minutes after the intervention
Body temperature
Body temperature: Celsius degree will be measured by means of a digital thermometer
Time frame: Change from baseline Body Temperature to seven days after the intervention
Cardiac frequency
Cardiac frequency: Beats per minute will be measured by means of OMRON M4 device, in compliance with the European Directive 93/42/EEC
Time frame: Change from baseline Cardiac Frequency to ten minutes after the intervention
Cardiac frequency
Cardiac frequency: Beats per minute will be measured by means of OMRON M4 device, in compliance with the European Directive 93/42/EEC
Time frame: Change from baseline Cardiac Frequency to seven days after the intervention
Arterial tension
Arterial tension (systolic/diastolic) will be measured by means of OMRON M4 device, in compliance with the European Directive 93/42/EEC
Time frame: Change from baseline arterial tension to ten minutes after the intervention
Arterial tension
Arterial tension (systolic/diastolic) will be measured by means of OMRON M4 device, in compliance with the European Directive 93/42/EEC
Time frame: Change from baseline arterial tension to seven days after the intervention
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.